Wassil Jiminsider trades
In SEC Form 4 filings, Wassil Jim is listed as EVP, Chief Scientific Ofc, COO of Vaxcyte, Inc. (PCVX). In the last 90 days, Wassil Jim sold $2.07M of Vaxcyte, Inc. (PCVX) on the open market and bought none. 3 of the 9 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | 18 | Oct 7 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PCVXVaxcyte, Inc. | Oct 5 | Oct 7 | M | 18,000 | $5.35 | $96,300 | 163,435 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Oct 5 | Oct 7 | S | 18,000 | $86.74 | Sale −$1,561,320 | 145,435 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Oct 5 | Oct 7 | M · derivative | 18,000 | $5.35 | $96,300 | 46,398 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Oct 1 | Oct 2 | M | 2,250 | $5.35 | $12,038 | 147,685 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Oct 1 | Oct 2 | S | 2,155 | $56.65 | Sale −$122,089 | 145,530 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Oct 1 | Oct 2 | S | 95 | $57.09 | Sale −$5,424 | 145,435 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Oct 1 | Oct 2 | M · derivative | 2,250 | $5.35 | $12,038 | 64,398 | Yes | Form 4 |
| PCVXVaxcyte, Inc. | Sep 9 | Sep 9 | S | 1,334 | $59.52 | Sale −$79,401 | 145,435 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 8 | Sep 9 | F | 5,459 | $60.36 | $329,505 | 146,769 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 4 | Sep 9 | S | 1,381 | $61.16 | Sale −$84,462 | 152,228 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 2 | Sep 2 | F | 1,432 | $61.58 | $88,183 | 153,609 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 1 | Sep 2 | M | 2,250 | $5.35 | $12,038 | 158,518 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 1 | Sep 2 | S | 1,537 | $60.89 | Sale −$93,582 | 156,981 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 1 | Sep 2 | S | 713 | $61.48 | Sale −$43,836 | 156,268 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 1 | Sep 2 | S | 924 | $60.96 | Sale −$56,322 | 155,344 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 1 | Sep 2 | S | 303 | $61.42 | Sale −$18,611 | 155,041 | No | Form 4 |
| PCVXVaxcyte, Inc. | Sep 1 | Sep 2 | M · derivative | 2,250 | $5.35 | $12,038 | 66,648 | No | Form 4 |
| PCVXVaxcyte, Inc. | Aug 31 | Sep 2 | F | 1,273 | $60.74 | $77,322 | 156,268 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.